PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
0.44%
Net income growth under 50% of CRWD's 101.35%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
5.86%
D&A growth well above CRWD's 10.26%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
13.45%
Lower deferred tax growth vs. CRWD's 48.48%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
-0.26%
Negative yoy SBC while CRWD is 10.44%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
184.85%
Well above CRWD's 160.01% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
-553.16%
Both yoy AR lines negative, with CRWD at -1259.33%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-78.85%
Both reduce yoy inventory, with CRWD at -213.66%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
548.77%
A yoy AP increase while CRWD is negative at -497.89%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
344.01%
Lower 'other working capital' growth vs. CRWD's 705.03%. David Dodd would see fewer unexpected short-term demands on cash.
53.75%
Well above CRWD's 9.78%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
16.54%
Operating cash flow growth at 50-75% of CRWD's 26.87%. Martin Whitman would worry about lagging operational liquidity vs. competitor.
-26.67%
Both yoy lines negative, with CRWD at -118.27%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
14.79%
Less M&A spending yoy vs. CRWD's 99.88%, reducing near-term risk. David Dodd would confirm the firm is not missing out on a strategic deal that competitor might exploit.
-29.68%
Negative yoy purchasing while CRWD stands at 97.45%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-32.34%
Both yoy lines are negative, with CRWD at -58.00%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
70.18%
Growth well above CRWD's 99.76%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-38.77%
We reduce yoy invests while CRWD stands at 104.35%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-54.86%
We cut debt repayment yoy while CRWD is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
2.30%
Lower share issuance yoy vs. CRWD's 1529.81%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
0.07%
Buyback growth of 0.07% while CRWD is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.